Join over 300 leaders at our renowned Biomarker event, discussing key opportunities and challenges in biomarker research and precision medicine
Featuring over 50 presentations, the event brings together leading pharma, biotech and academic organisations working in the biomarker space across multiple therapeutic areas, enabling attendees to gain insights into the latest novel biomarker data and technologies
An in-depth conference on how the latest digital technologies can transform the future of healthcare and the process of clinical trials. Learn about digital biomarkers in clinical trials, emerging applications in drug development and pathology tools within oncology biomarker development.
Over 300 attendees representing global pharmaceutical organisations, leading biotech & diagnostic companies and internationally renowned academic and healthcare institutions working in the biomarker space across multiple therapeutic areas
Over 50 presentation and case studies focussed on the key opportunities and challenges in translational science, personalised medicine and clinical development
Digital Biomarkers in Clinical Research
Emerging Applications in Drug Development
Emerging Tools and Technologies for Digital Biomarkers
Digital Pathology & Biomarker Development
The 2021 event brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.
Below were some of the speakers of Biomarkers Series US: Virtual 2020
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of virtual experiences.
*Free passes are only available to industry R&D or academia.